| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Toy Andrew | Chief Executive Officer, Director | C/O CLOVER HEALTH INVESTMENTS, CORP., NOT APPLICABLE, WILMINGTON | /s/Peter J. Rivas as attorney-in-fact for Andrew Toy | 05 Jan 2026 | 0001838733 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLOV | Class A Common Stock | Tax liability | $629,701 | -267,958 | -2.7% | $2.35 | 9,569,489 | 01 Jan 2026 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 1, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. |